Increasing Interest in Stem Cell Research
Stem cells are now being considered as a treatment option for regenerative and for lifesaving therapies. Research on the ethically sourced adult stem cells has been garnering popularity since 2010. The drug manufacturing companies have initiated stem cell research and several players in the pharmaceutical industry are using these cells to test the toxicity of drugs, which helps them identify new therapies. These researchers and pharmaceutical companies are studying stem cells for basic research, toxicity test, drug discovery, and future applications. A wide range of reagents, such as stem cell culture media, laboratory reagents, etc., are necessary to meet the stem cell culture needs. With the booming stem cell research, it is anticipated that the demand for biotechnology reagents will grow over the forecast period.
The other factors that also drive the market are - exponential rise of the biotechnology industry across the globe, significant investments by private players in R&D, and rise in
the number of market players.
High Cost of Reagents
The reagents used for life science research usually involve high costs. Hence, availability of the services that require reagents in the developing regions is often limited by the high costs associated with reagents. To counter this issue, various measures are being undertaken, such as manufacturing of low-cost reagents. Local development of reagents may become a time-consuming process, as most of the reagents manufactured by the local companies may result in low-quality reagents. Therefore, high costs act as a barrier for the market studied.
Stringent government regulations for the approval of reagents are expected to lead to a fall in the demand for reagents and lack of skilled personnel to handle the reagents, thus hampering the growth of the market studied.
North America Dominates the Biophotonics Market
North America dominates the global biotechnology reagents market and incurs the highest expenditure for global R&D. The United States accounted for the largest share of 73%, in 2016. The North American segment is on a rise, because of the ongoing research in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of biotechnology reagents in the market. Due to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.
Key Developments in the Market
- August 2016: GE Healthcare expanded its cell therapy portfolio, with the license of STEMCELL Technologies T-Cell reagents.
Reasons to Purchase this Report
- Current and future biotechnology reagents market outlook in the developed and emerging markets.
- Analyzing various perspectives of the market, with the help of Porter’s five forces analysis.
- The segment that is expected to dominate the market.
- The regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet (in Excel)
This report can be customized to meet your requirements..
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Significant Investments by Private Players in Biotechnology
6.1.2 Increasing Interest in Stem Cell Research
6.1.3 Growing Number of Biotechnology Firms
6.1.4 Increasing Usage of Reagents in Commercial and Research Fields
6.2 Market Restraints
6.2.1 Stringent Government Regulations for Approval of Reagents
6.2.2 High Cost of Reagents
6.2.3 Contamination Problems
6.4 Key Challenges
7. Market Segmentation
7.1 By Technology
7.1.1 Life Science Reagents
184.108.40.206 Cell Culture
220.127.116.11 In-vitro Diagnostics
18.104.22.168 Expression and Transfection
7.1.2 Analytical Reagents
22.214.171.124 Mass Spectrometry
126.96.36.199 Flow Cytometry
7.2 By Application
7.2.1 Protein Synthesis and Purification
7.2.2 Gene Expression
7.2.3 DNA and RNA Analysis
7.2.4 Drug Testing
7.3 By Geography
7.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 Australia & New Zealand
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
7.3.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East & Africa
7.3.5 South America
220.127.116.11 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 GE Healthcare
9.2 Siemens Healthcare
9.4 Waters Corp.
9.5 Beckman Coulter
9.8 EMD Biosciences
9.9 Bio Rad Laboratories
9.10 Sigma Aldrich
9.11 List not Exhaustive
10. Future of the Market